Filtered By:
Management: Government
This page shows you your search results in order of date. This is page number 2.
Order by Relevance | Date
Total 334 results found since Jan 2013.
Fauci hits back at Elon Musk ' s prosecution call: " Off the deep end "
Dr. Anthony Fauci responded to Elon Musk's tweet calling for the government to prosecute the now-retired health official over the COVID-19 pandemic. Fauci, who served as the director of the National Institute of Allergy and Infectious Diseases for a nearly four-decade span that included the…#anthonyfauci #elonmusk #fauci #twitter #republicans #prosecutefauci #conservatives #tedcruz
Source: Reuters: Health - March 11, 2023 Category: Consumer Health News Source Type: news
Science takes back seat to politics in first House hearing on origin of COVID-19 pandemic
Some scientists and legislators might have hoped this morning’s U.S. congressional hearing on the origin of the COVID-19 pandemic would move beyond partisan politics and seriously investigate what has become a
deeply divisive debate
. But members of the House of Representatives’s Select Subcommittee on the Coronavirus Pandemic mostly hammered home long-standing Republican or Democratic talking points, shedding no new light on the central question: Did SARS-CoV-2 naturally jump from animals to humans or did the virus somehow leak from a laboratory in Wuhan, China?
“It was very disappointing, and almost unbe...
Source: Science of Aging Knowledge Environment - March 8, 2023 Category: Geriatrics Source Type: research
The Pandemic Sparked a Revolution in Trans Care. Washington May Let it Fade Away
This article is part of The D.C. Brief, TIME’s politics newsletter. Sign up here to get stories like this sent to your inbox.
When the Covid-19 pandemic reached US shores roughly three years ago this month, it changed everything, including how we handled the medical needs of those who were lucky enough to not have caught Covid-19. Policymakers in Washington didn’t know a lot at that point but they had more than a hunch that it was in everyone’s best interest to keep patients who weren’t battling Covid-19 from sharing the same waiting rooms as those who were, especially if the reason they were meetin...
Source: TIME: Health - February 17, 2023 Category: Consumer Health News Authors: Philip Elliott Tags: Uncategorized Biden Administration Health Care LGBTQ The D.C. Brief Source Type: news
N.I.H. Did Not Properly Track a Group Studying Coronaviruses, Report Finds
An internal federal watchdog said that the health agency had not given adequate oversight to EcoHealth Alliance, which had been awarded $8 million in grants.
Source: NYT - January 26, 2023 Category: American Health Authors: Benjamin Mueller and Sheryl Gay Stolberg Tags: Coronavirus (2019-nCoV) United States Politics and Government Research Nonprofit Organizations Laboratories and Scientific Equipment EcoHealth Alliance National Institute of Allergy and Infectious Diseases National Institutes of Health Fau Source Type: news
Now in charge, House Republicans launch flurry of investigations
The new Republican majority in the U.S. House of Representatives is preparing to shine a bright light on science—and scientists. This week, it created two investigative panels that will scrutinize the country’s relationship with China and its response to the COVID-19 pandemic. Both committees are expected to grill many prominent scientists and federal research officials on their actions over the past several years.
In approach and style, however, they are likely to be very different. The China panel, officially the Select Committee on Strategic Competition between the United States and the Chinese Communist Party,...
Source: Science of Aging Knowledge Environment - January 13, 2023 Category: Geriatrics Source Type: research
Anthony Fauci Prepares for Retirement After Half a Century in Government
The nation ’s top infectious disease expert, whose last day as a federal employee is Saturday, plans to write a memoir and wants to encourage people to go into public service.
Source: NYT Health - December 29, 2022 Category: Consumer Health News Authors: Sheryl Gay Stolberg Tags: Fauci, Anthony S Content Type: Personal Profile Coronavirus (2019-nCoV) Vaccination and Immunization National Institute of Allergy and Infectious Diseases United States Politics and Government Government Employees Medicine and Health Source Type: news
Dr. Anthony Fauci Is Stepping Down. Here ’s His Advice For His Successor
After Dr. Anthony Fauci steps down as head of the National Institute of Allergy and Infectious Diseases (NIAID) and chief medical advisor to President Biden on Dec. 31, he’ll leave behind a long and storied career. Ahead of his last day, he spoke to TIME from his office at the National Institutes of Health about what’s next for him—and his advice for whoever fills his shoes.
This interview has been edited and condensed for clarity.
TIME: You’re leaving your leadership positions in the federal government, but you aren’t retiring. What are you calling the next stage in your career?
[time-brightc...
Source: TIME: Health - December 20, 2022 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
Science ’s 2022 Breakthrough of the Year: A telescope’s golden eye sees the universe anew
html { scroll-behavior: smooth; } .news-article-content--featured>.bodySection>.mb-2x:not(:first-of-type) { display: none; } h3 { scroll-margin-top: 5rem; } .parent-section h3, .subsection h3 { font-size: 1.375rem; line-height: 1.875rem; } .news-article-content-footer h2 { display: none; } .toc img { padding-bottom: 16px; transition: opacity .25s; } .toc img:hover { opacity: 60%; } .toc .image-grid img { padding-bottom: 16px; padding-top: 16px; } .image-grid .news-article__figure__image__wrapper:before, .image-grid .news-article__figure__image__wrapper:after { display: none; } .news-article-content sectio...
Source: ScienceNOW - December 15, 2022 Category: Science Source Type: news
Why Anthony Fauci Is Still Optimistic About Science
Anthony Fauci will step down as director of the National Institute of Allergy and Infectious Diseases this month, leaving behind a government career that spans 54 years, 38 in his current role. As he prepares to depart NIAID, I talked with Fauci about the scientific challenges left on the table,…#lj #cdc #bloombergopinion #nationalinstituteofallergyandinfect #bloomberglp #fauci #chemicalengineeringnews #anthonyfauci #malaria #lisajarvis
Source: Reuters: Health - December 5, 2022 Category: Consumer Health News Source Type: news
Why the U.S. Doesn ’t Have a Nasal Vaccine for COVID-19
The U.S. led the world in quickly developing COVID-19 vaccines—one of the few bright spots in the country’s otherwise criticized response. But while injectable vaccines are effective in protecting people from getting sick with COVID-19, they are less able to block infection. In order to put the pandemic behind us, the world will need a way to stop infections and spread of the virus. That’s where a different type of vaccine, one that works at the places where the virus gets into the body, will likely prove useful.
Here, though, the U.S. is losing its edge. In September, India approved a nasal COVID-19 vacc...
Source: TIME: Health - October 31, 2022 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
A New Lab-Made COVID-19 Virus Puts Gain-of-Function Research Under the Microscope
On October 14, a team of scientists at Boston University released a pre-print study reporting that they had created a version of SARS-CoV-2 combining two features of different, existing strains that boosted its virulence and transmissibility. Scientists and the public raised questions about the work, which refocused attention on such experiments, and prompted the U.S. government to investigate whether the research followed protocols for these kinds of studies.
The concerns surround what is known as gain-of-function studies, in which viruses, bacteria, or other pathogens are created in the lab—either intentionally or ...
Source: TIME: Science - October 27, 2022 Category: Science Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news
U.S. weighs crackdown on experiments that could make viruses more dangerous
.news-article__hero--featured .parallax__element{ object-position: 50% 40%; -o-object-position: 50% 40%; } .scroll-wrapper { overflow-x: auto; } .scroll-wrapper .news-article__figure__image{ width: 2680px; max-width: none; padding-bottom: .75rem; } .scroll-fade-before, .scroll-fade-after { position: absolute; width: 1.5rem; transition-duration: .1s; opacity: 1; } .scroll-fade-before { left: 1rem; /*margin-left: -1px;*/ background: linear-gradient(90deg, #fff, #fff 35%, hsla(0, 0%, 100%, 0)); } .scroll-fade-after { right: 1rem; /*margin-right: -1px;*/ background: linear-gradient(270deg, #fff, #fff 35%, hsla(0,...
Source: ScienceNOW - October 19, 2022 Category: Science Source Type: news
Was a study that created a hybrid COVID-19 virus too risky?
The objective was to tease apart whether Omicron’s spike protein explains why it is less pathogenic (meaning it causes less severe disease). The answer could lead to improved COVID-19 diagnostic tests and better ways to manage the disease, the preprint authors say.
Somewhat surprisingly, the hybrid virus killed eight of 10 infected mice, whereas mice infected with Omicron got sick but did not die. This suggests the mutations that make Omicron less pathogenic must involve changes in proteins other than the spike protein, the authors say.
What are critics of the study saying?
They question the scientific val...
Source: Science of Aging Knowledge Environment - October 18, 2022 Category: Geriatrics Source Type: research
Scientists race to test vaccines for Uganda ’s Ebola outbreak
A multipronged international effort has begun to pull out all the stops to launch trials of experimental Ebola vaccines in Uganda, which declared an outbreak of the deadly disease on 20 September. According to the most recent World Health Organization (WHO) update, Uganda has had 18 confirmed and 18 suspected cases of Ebola, including 23 deaths—an unusually high case fatality rate of 64%. A trial of a vaccine candidate that’s farthest along in development could launch before the end of next month.
Proven vaccines exist for Zaire ebolavirus, which has led to a dozen outbreaks in the neighboring Democratic Republic ...
Source: ScienceNOW - September 29, 2022 Category: Science Source Type: news
Anthony Fauci, loved and hated, plots his next move: ‘I'm not going to sit in my house’
In 1984, when Anthony Fauci took over as head of the National Institute of Allergy and Infectious Diseases (NIAID), his wife gave him a plant for the new office. Both the palm and the 81-year-old physician are still there, the giant plant now crowding the office of one of the most celebrated—and polarizing—scientific figures in U.S. history. But not for much longer. Fauci announced on 22 August that he would step down at the end of the year from both NIAID and his post as the chief medical adviser to President Joe Biden.
“What am I going to do with this plant? It’s a monster. I can’t fit it in any other plac...
Source: ScienceNOW - September 1, 2022 Category: Science Source Type: news
